This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Tenofovir in Late Pregnancy to Prevent Vertical Tr...
Clinical trial

Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus

Read time: 1 mins
Last updated:30th Nov 2011
Tenofovir Disoproxil (TDF), a pregnancy category B medication, reduces HBV DNA and normalizes serum ALT in chronic hepatitis B patients (CHB) with few adverse effects. Two aspects on tenofovir use in pregnancy will be evaluated prospectively in this study: - the data on its tolerability and safety in HBeAg+ pregnant women with HBV DNA > 6log10 copies/mL during late pregnancy and infants - Its efficacy in the reduction of HBV vertical transmission rate
Category Value
Study start date 2011-11-30

View full details